SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000921895-22-001874
Filing Date
2022-06-02
Accepted
2022-06-02 09:46:10
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4a13398002_06022022.html 4/A  
1 OWNERSHIP DOCUMENT form4a13398002_06022022.xml 4/A 5171
  Complete submission text file 0000921895-22-001874.txt   6697
Mailing Address 1201 NORTH MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address
Javitt Jonathan C (Reporting) CIK: 0001303782 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38302 | Film No.: 22989414

Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations